During the consultation on the draft guidance Janssen, the manufacturer of the drug, submitted further information for the committee to consider.
This included a revised patient access scheme which involves providing the drug to the NHS at a discounted price, further information on which patients would benefit most and clarification on how many patients could receive the drug.
These factors enabled the committee to revise its preliminary recommendation and now recommend the drug for use on the NHS.
More top news
An Irish man has become an unwitting internet star after his Facebook profile picture was photoshopped dozens of times.
Stranded refugees and migrants clashed with police after young Moroccan man accidentally electrocuted himself
The flame-haired royal is an accomplished polo player but that didn't stop him taking a tumble not once, but twice, during the game.